荣泰健康: 上海荣泰健康科技股份有限公司关于提前赎回“荣泰转债”的公告

Group 1 - The company announced the early redemption of its convertible bonds "Rongtai Convertible Bonds" due to the triggering of conditional redemption clauses [4][6][7] - The initial issuance of the convertible bonds was approved by the China Securities Regulatory Commission, with a total amount of 600 million yuan and a tiered interest rate structure over six years [1][2] - The conversion price of the bonds has been adjusted multiple times due to annual profit distribution, with the latest adjustment setting the price at 23.07 yuan per share [3][5][6] Group 2 - The company’s stock price has met the condition for redemption, with the closing price exceeding 130% of the current conversion price for at least 15 trading days [4][7] - The board of directors has authorized the management to handle all matters related to the redemption process, including determining the redemption date and procedures [7][8] - There have been no transactions of the convertible bonds by major shareholders and executives in the six months prior to the redemption condition being met [8][9]